Targeted inhibition of farnesyltransferase in locally advanced breast cancer: A phase I and II trial of tipifarnib plus dose-dense doxorubicin and cyclophosphamide
Joseph A. Sparano, Stacy Moulder, Aslamuzzaman Kazi, Linda Vahdat, Tianhong Li, Christine Pellegrino, Pam Munster, Mokenge Malafa, David Lee, Shira Hoschander, Una Hopkins, Dawn Hershman, John J. Wright, Said M. Sebti
Dive into the research topics of 'Targeted inhibition of farnesyltransferase in locally advanced breast cancer: A phase I and II trial of tipifarnib plus dose-dense doxorubicin and cyclophosphamide'. Together they form a unique fingerprint.